1 results match your criteria: "is an Employee at Clinical Research Neuroscience[Affiliation]"
Acceptance of the extracare program by Beta interferon-treated patients with multiple sclerosis: results of the explore study.
J Neurosci Nurs
February 2015
Matthias Freidel, MD, is a Neurologist and Psychiatrist at Neurologische Praxis, Kaltenkirchen, Germany. Sonja Ortler, PhD, is an Employee at Clinical Research Neuroscience, Novartis Pharma GmbH, Nuremberg, Germany. Questions or comments about this article may be directed to Alexander Fuchs, PhD, at He is an Employee at Clinical Research Neuroscience, Novartis Pharma GmbH, Nuremberg, Germany. Sabine Seibert, PhD, is an Employee at Clinical Research Neuroscience, Novartis Pharma GmbH, Nuremberg, Germany. Katrin Schuh, PhD, is an Employee at Clinical Research Neuroscience, Novartis Pharma GmbH, Nuremberg, Germany.
Background: To gain full benefit from disease-modifying therapies such as interferon β-1b, patients with multiple sclerosis (MS) need to adhere to treatment in the long term. Treatment adherence requires high patient satisfaction with treatment and care.
Objectives: Our aim was to evaluate the satisfaction of patients with MS receiving interferon β-1b Extavia with the patient care program Extracare.